Voyager Therapeutics, Inc. (VYGR) Live Share Price, Invest From India

Voyager Therapeutics, Inc. Stock Performance

as on April 3, 2026 at 6:59 am IST

Day's Low
Day's High
$3.80
Day's Price Range
$3.96
$3.95
3.80%
Downside
0.25%
Upside
52 Week's Low
52 Week's High
$2.65
52-Week Price Range
$5.55
$3.95
33.04%
Downside
40.51%
Upside

Voyager Therapeutics, Inc. share price movements today

Previous Close: $3.99
Open: $3.91
Volume: 531.0K
Day's Low - High: $3.80 - $3.96
52 Week Low - High: $2.65 - $5.55

Voyager Therapeutics, Inc. Historical Returns

1 Month Return: -4.12 %
3 Month Return: -1.74 %
1 Year Return: + 28.16 %
3 Year Return: -48.64 %
5 Year Return: -18.35 %

Voyager Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Voyager Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$236.0M

EPS (TTM)

-1.7741

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

39.47

Industry PE ratio

-1.8666504854368933

PEG Ratio

EBITDA

-124.3M

Revenue (TTM)

40.4M

Profit Margin

-296.53%

Return On Equity TTM

-48.29%

Voyager Therapeutics, Inc. Stock Valuation

Track how Voyager Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Voyager Therapeutics, Inc. in the last 5 years

Overview
Trends

Lowest (-168.84x)

March 31, 2024

Industry (-1.87x)

April 4, 2026

Today (39.47x)

April 4, 2026

Highest (29.94x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 39.47x

Voyager Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Voyager Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Voyager Therapeutics, Inc.	BUY	$236.0M	-18.35%	39.47	-296.53%
Alnylam Pharmaceuticals, Inc.	BUY	$42.3B	124.84%	136.85	8.45%
Beone Medicines Ltd	NA	$35.7B	NA	125.83	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$111.4B	105.93%	28.66	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$80.5B	60.41%	18.38	31.41%

Stock Returns calculator for Voyager Therapeutics, Inc. Stock including INR - Dollar returns

The Voyager Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Voyager Therapeutics, Inc. investment value today

Current value as on today

₹1,37,936

Returns

₹37,936

(+37.94%)

Returns from Voyager Therapeutics, Inc. Stock

₹27,832 (+27.83%)

Dollar Impact

₹10,104 (+10.1%)

Analyst Recommendation on Voyager Therapeutics, Inc. Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Voyager Therapeutics, Inc.. Average target price of $14.89

Voyager Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Voyager Therapeutics, Inc..

What analysts predicted

73.47%UPSIDE

Target Price

$14.89

Current Price

$3.95

Analyzed by

16 Analysts

Target

$14.89

Voyager Therapeutics, Inc. target price $14.89, a slight upside of 73.47% compared to current price of $3.95. According to 16 analysts rating.

Voyager Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Voyager Therapeutics, Inc. Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 6, 2026 to April 5, 2026

Change:17% versus previous 30 day period

Voyager Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	4	90	19	29	24	6	6	5	13	15
Gross Profit	-21	88	18	-2	24	6	6	5	13	15
Operating Income	-29	54	-16	-15	-13	-38	-34	-36	-30	-29
EBITDA	-28	58	-14	-11	-12	-37	-33	-35	-26	-28
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	1	1	1	1	1	1	1	0	1
Income Before Tax	-25	57	-11	-10	-9	-33	-30	-33	-27	-27
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-25	56	-11	-10	-9	-34	-31	-33	-27	-27
Net Profit Margin	-561.36%	62.62%	-58.05%	-34.29%	-36.72%	-549.33%	-479.24%	-641.96%	-208.69%	-178.83%

Voyager Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	14	10	7	104	171	37	40	250	80	40
Gross Profit	14	10	7	104	62	37	40	157	80	40
Operating Income	-41	-71	-91	-51	27	-73	-50	122	-83	-131
EBITDA	-40	-70	-88	-48	31	-68	-44	126	-78	-127
Interest Expense	0	-	-	-	-	0	1	-	-	-
Depreciation	-	1	2	2	3	5	6	4	4	4
Income Before Tax	-40	-70	-88	-43	36	-71	-46	133	-64	-119
Income Tax Expense	0	-1	0	-2	-1	-5	0	1	0	0
Net Income	-40	-70	-88	-40	36	-66	-46	132	-65	-119
Net Profit Margin	-282.65%	-697.56%	-1158.79%	-39.11%	21.47%	-176.49%	-113.45%	52.93%	-81.25%	-296.53%

Voyager Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	56	-11	-10	-9	-34	-31	-33	-27	-27
Operating Cash Flow	-23	58	-31	-27	-14	-37	-33	-31	-30
Investing Cash Flow	26	-96	-35	64	-27	41	1	34	47
Financing Cash Flow	0	112	0	0	0	0	0	0	0
Change in Cash	3	75	-66	36	-41	3	-30	1	17

Voyager Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-70	-88	-43	36	-71	-46	132	-65	-119
Operating Cash Flow	-61	-15	48	-96	-53	-12	77	-15	-132
Investing Cash Flow	-3	26	-90	112	65	-7	-141	-94	125
Financing Cash Flow	59	4	80	3	0	1	33	114	0
Change in Cash	-5	15	39	18	12	-18	-30	3	-6

Global Institutional Holdings in Voyager Therapeutics, Inc.

Funds	Holdings
Vanguard Group Inc	5.53%
Millennium Management LLC	4.12%
Erste Asset Management GmbH	2.02%
Royal Bank of Canada	0.52%
Goldman Sachs Group Inc	0.51%

See all

Insights on Voyager Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -33.38M → -27.42M (in $), with an average increase of 10.7% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 5.2M → 15.33M (in $), with an average increase of 37.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 7.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 107.4%

About Voyager Therapeutics, Inc.

voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.

Organisation	Voyager Therapeutics, Inc.
Headquarters	75 Hayden Avenue, Lexington, MA, United States, 02421
Industry	Health Technology
CEO	Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Voyager Therapeutics, Inc.

Name	Title
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.	President, CEO & Director
Dr. Nathan D. Jorgensen M.B.A., Ph.D.	Chief Financial Officer
Dr. Krystof Bankiewicz M.D., Ph.D.	Founder
Dr. Mark A. Kay M.D., Ph.D.	Founder
Ms. Trista Morrison	Chief Corporate Affairs Officer & Chief of Staff to the CEO

FAQs

What is Voyager Therapeutics, Inc. share price today?

Voyager Therapeutics, Inc. share price today is $3.95 as on April 3, 2026 at 1:29 am IST at the close of the market. Voyager Therapeutics, Inc. share today touched a day high of $3.96 and a low of $3.8.

What is the 52 week high and 52 week low for Voyager Therapeutics, Inc. share?

Voyager Therapeutics, Inc. share touched a 52 week high of $5.55 on October 16, 2025 and a 52 week low of $2.65 on May 30, 2025. Voyager Therapeutics, Inc. stock price today i.e. April 3, 2026 at 1:29 am IST is closed at $3.95,which is 28.83% down from its 52 week high and 49.34% up from its 52 week low.

What is Voyager Therapeutics, Inc.'s market capitalisation today?

Voyager Therapeutics, Inc. market capitalisation is $0.00T as on April 3, 2026 at 1:29 am IST.

How to invest in Voyager Therapeutics, Inc. Stock (VYGR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Voyager Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Voyager Therapeutics, Inc. Shares that will get you 0.3797 shares as per Voyager Therapeutics, Inc. share price of $3.95 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Voyager Therapeutics, Inc. Stock (VYGR) from India?

Indian investors can start investing in Voyager Therapeutics, Inc. (VYGR) shares with as little as ₹92.67 or $1 (as of April 5, 2026 at 6:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Voyager Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on April 5, 2026 at 6:41 pm IST). Based on Voyager Therapeutics, Inc. share’s latest price of $3.95 as on April 3, 2026 at 1:29 am IST, you will get 2.5316 shares of Voyager Therapeutics, Inc.. Learn more about fractional shares .

What are the returns that Voyager Therapeutics, Inc. has given to Indian investors in the last 5 years?

Voyager Therapeutics, Inc. stock has given -18.35% share price returns and 26.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?